Memorial Sloan-Kettering Cancer Center (MSKCC) is a freestanding institution, founded as the New York Cancer Hospital in 1884 and now located in the upper east side of New York city, adjacent to the health sciences campuses of Cornell Medical College and Rockefeller University. The Center's mission is the progressive control and cure of cancer through programs of research, patient care, and education. MSKCC is dedicated to the study of cancer through a defined spectrum of laboratory research, an interactive program spanning basic and clinical science, a strong capability for basic-to-clinic technology transfer, a structured program of clinical cancer research, state-of-the-art clinical programs, including in-patient and extensive out-patient clinical care, community care focused on early diagnosis and specific cancers and a strategically selected set of priorities in cancer control and prevention that addresses issues of both local and national importance. The research activities of MSKCC are administratively organized in seven research programs: Molecular Biology, Cell Biology & Genetics, Cellular Biochemistry & Biophysics, Immunology, Molecular Pharmacology & Therapeutics, Clinical Research, and Cancer Control & Prevention. One of these, Cellular Biochemistry & Biophysics, is a """"""""developing program"""""""" according to the CCSG guidelines. These Programs are supported by 17 CCSG-supported Core Facilities as well as others supported entirely by institutional resources. The Core Facilities for which CCSG support is requested are: Preparative Synthesis, Nuclear Magnetic Resonance, Pharmacology Analytical Facility, General Animal Facility, Animal Health Service, Transgenic Mouse Facility, Glassware Washing, Core Media Preparation, Flow Cytometry, Cyclotron, Microchemistry, Cytogenetics, Human Tumor Procurement, Biosafety, Biostatistics, Clinical Research Support, and the Research Pharmacy. Funds are also requested for Planning & Evaluation and for Development.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA008748-30
Application #
2084605
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1977-01-01
Project End
1997-12-31
Budget Start
1995-02-10
Budget End
1995-12-31
Support Year
30
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Arvold, Nils D; Armstrong, Terri S; Warren, Katherine E et al. (2018) Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group. Neuro Oncol 20:897-906
De, Brian; Cahlon, Oren; Sine, Kevin et al. (2018) Early Axial Growth Outcomes of Pediatric Patients Receiving Proton Craniospinal Irradiation. J Pediatr Hematol Oncol 40:574-579
Chang, Kevin K; Yoon, Changhwan; Yi, Brendan C et al. (2018) Platelet-derived growth factor receptor-? and -? promote cancer stem cell phenotypes in sarcomas. Oncogenesis 7:47
Dupnik, K M; Bean, J M; Lee, M H et al. (2018) Blood transcriptomic markers of Mycobacterium tuberculosis load in sputum. Int J Tuberc Lung Dis 22:950-958
Roberts, Sheryl; Andreou, Chrysafis; Choi, Crystal et al. (2018) Sonophore-enhanced nanoemulsions for optoacoustic imaging of cancer. Chem Sci 9:5646-5657
Romanoff, Anya; Zabor, Emily C; Petruolo, Oriana et al. (2018) Does nonmetastatic inflammatory breast cancer have a worse prognosis than other nonmetastatic T4 cancers? Cancer 124:4314-4321
Schaff, Lauren R; Grommes, Christian (2018) Updates on Primary Central Nervous System Lymphoma. Curr Oncol Rep 20:11
Suryawanshi, Hemant; Morozov, Pavel; Straus, Alexander et al. (2018) A single-cell survey of the human first-trimester placenta and decidua. Sci Adv 4:eaau4788
Pandit-Taskar, Neeta (2018) Functional Imaging Methods for Assessment of Minimal Residual Disease in Multiple Myeloma: Current Status and Novel ImmunoPET Based Methods. Semin Hematol 55:22-32
Kamboj, Mini; Cohen, Nina; Huang, Yao-Ting et al. (2018) Impact of Empiric Treatment for Vancomycin-Resistant Enterococcus in Colonized Patients Early after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant :

Showing the most recent 10 out of 8799 publications